Research output per year
Research output per year
Personal profile
Research interests
Mika Kontro, MD, PhD is an associate professor and a consultant in clinical hematology at the Helsinki University Hospital Comprehensive Cancer Center. Mika Kontro earned his PhD thesis, entitled “Individualizing therapy for acute leukemia”, in 2017.
He currently works as K. Albin Johannson Cancer Research Fellow (Finnish Cancer Institute) and as a clinical group leader in FIMM. He has a strong background in running clinical trials and was selected at 2017 for European Hematology Association Clinical Research Training program (CRTH). Mika Kontro currently chairs the Finnish AML group and is a board member of the Nordic AML Group. Currently he leads a prospective multi-center AML trial VenEx utilizing ex-vivo drug sensitivity testing for individualized patient care.
Fields of Science
- 3122 Cancers
International and National Collaboration
Publications and projects within past five years.
-
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
Kuusanmäki, H., Dufva, O., Vähä-Koskela, M., Leppä, A-M., Huuhtanen, J., Vänttinen, I., Nygren, P., Klievink, J., Bouhlal, J., Pölönen, P., Zhang, Q., Adnan-Awad, S., Mancebo-Pérez, C., Saad, J., Miettinen, J., Javarappa, K. K., Aakko, S., Ruokoranta, T., Eldfors, S., Heinäniemi, M., & 9 others, 30 Mar 2023, In: Blood. 141, 13, p. 1610-1625 16 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
Kuusanmaki, H., Kytölä, S., Vänttinen, I., Ruokoranta, T., Ranta, A., Huuhtanen, J., Suvela, M., Parsons, A., Holopainen, A., Partanen, A., Kuusisto, M. E. L., Koskela, S., Räty, R., Itälä-Remes, M., Västrik, I., Dufva, O., Siitonen, S., Porkka, K., Wennerberg, K., Heckman, C. A., & 5 others, Jul 2023, In: Haematologica. 108, 7, p. 1768-1781 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML
Batcha, A. M. N., Buckup, N., Bamopoulos, S. A., Jurinovic, V., Rothenberg-Thurley, M., Gittinger, H., Ksienzyk, B., Dufour, A., Schneider, S., Kontro, M., Saad, J., Heckman, C. A., Sauerland, C., Goerlich, D., Berdel, W. E., Woermann, B. J., Krug, U., Braess, J., Mansmann, U., Hiddermann, W., & 3 others, 28 Mar 2023, In: Blood advances. 7, 6, p. 1040-1044 5 p.Research output: Contribution to journal › Letter › Scientific
-
Myelodysplastinen oireyhtymä - monimuotoinen kirjo verisairauksia
Kauppila, M., Holopainen, A., Kontro, M., Kytölä, S., Lehto, M., Laine, O., Myllymäki, M., Rounioja, S., Siitonen, T. & Ebeling, F., 2023, In: Duodecim. 139, 15, p. 1161-1168 8 p.Research output: Contribution to journal › Review Article › peer-review
-
Personalizing precision medicine: Patients with AML perceptions about treatment decisions
Grauman, Å., Kontro, M., Haller, K., Nier, S., Aakko, S., Lang, K., Zingaretti, C., Meggiolaro, E., De Padova, S., Marconi, G., Martinelli, G., Heckman, C. A., Simonetti, G., Bullinger, L. & Kihlbom, U., 2023, In: Patient Education and Counseling. 115, 6 p., 107883.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Projects
- 4 Active
-
Kontro/Suomen Hematologiyhdist.apuraha
Suomen hematologiyhdistys ry (SHY)
15/02/2023 → 31/12/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
AMLDT: A Prototype System for AML Digital Twins
Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2027
Project: Academy of Finland: Bilateral partnerships, joint calls
-
Sohlbergin säätiö 2023 Mika Kontro
Päivikki ja Sakari Sohlbergin säätiö sr.
01/01/2023 → 31/12/2023
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-